Wells Fargo & Company Bio Techne Corp Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Bio Techne Corp stock. As of the latest transaction made, Wells Fargo & Company holds 150,176 shares of TECH stock, worth $8.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,176

Previous 49,271 204.8%

Holding current value

$8.92 Million

Previous $2.53 Million 229.68%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$49.87 - $58.78 $5.03 Million - $5.93 Million	100,905 Added 204.8%	150,176 $8.35 Million
Q2 2025 Aug 14, 2025	BUY	$46.66 - $58.38 $85,201 - $106,601	1,826 Added 3.85%	49,271 $2.53 Million
Q1 2025 May 13, 2025	SELL	$58.47 - $78.75 $231,073 - $311,220	-3,952 Reduced 7.69%	47,445 $2.78 Million
Q4 2024 Feb 12, 2025	SELL	$66.37 - $78.17 $2.31 Million - $2.72 Million	-34,826 Reduced 40.39%	51,397 $3.7 Million
Q3 2024 Nov 13, 2024	BUY	$70.96 - $82.35 $890,831 - $1.03 Million	12,554 Added 17.04%	86,223 $6.89 Million

Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $867,257 - $1.17 Million	-13,961 Reduced 15.93%	73,669 $5.28 Million
Q1 2024 May 10, 2024	BUY	$65.98 - $77.09 $340,126 - $397,398	5,155 Added 6.25%	87,630 $6.17 Million
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $1.37 Million - $2.03 Million	26,005 Added 46.05%	82,475 $6.36 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $2.28 Million - $3.02 Million	-33,729 Reduced 37.39%	56,470 $3.84 Million
Q2 2023 Aug 15, 2023	BUY	$73.76 - $85.98 $344,459 - $401,526	4,670 Added 5.46%	90,199 $7.36 Million
Q1 2023 May 12, 2023	SELL	$71.62 - $86.62 $6.39 Million - $7.73 Million	-89,224 Reduced 51.06%	85,529 $6.35 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $10.9 Million - $47.5 Million	134,744 Added 336.78%	174,753 $14.5 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $944,531 - $1.31 Million	-3,343 Reduced 7.71%	40,009 $11.4 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $16.8 Million - $23.4 Million	-51,992 Reduced 54.53%	43,352 $15 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $13 Million - $18 Million	36,876 Added 63.07%	95,344 $41.3 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $91.5 Million - $105 Million	-200,525 Reduced 77.42%	58,468 $30.2 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $20.2 Million - $24.4 Million	45,308 Added 21.2%	258,993 $126 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $9.71 Million - $11.3 Million	-25,056 Reduced 10.5%	213,685 $96.2 Million
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $1.93 Million - $2.52 Million	6,130 Added 2.64%	238,741 $91.2 Million
Q4 2020 Feb 09, 2021	BUY	$246.9 - $321.87 $7.23 Million - $9.42 Million	29,269 Added 14.39%	232,611 $73.9 Million
Q3 2020 Nov 05, 2020	BUY	$232.22 - $282.96 $35.8 Million - $43.6 Million	154,182 Added 313.63%	203,342 $50.4 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $827,759 - $1.25 Million	-4,464 Reduced 8.32%	49,160 $13 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $8.64 Million - $11.9 Million	53,624 New	53,624 $10.2 Million

Others Institutions Holding TECH

# of Institutions

648

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bio Techne Corp Transaction History